Financial Engines Advisors
VKTX icon

Financial Engines Advisors’s Viking Therapeutics VKTX Stock Holding History

Financial Engines Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Sell
15,584
-77
-0.5% -$2.49K ﹤0.01% 378
2026
Q1 		$510K Buy
15,661
+46
+0.3% +$1.48K ﹤0.01% 386
2025
Q4 		$549K Buy
15,615
+763
+5% +$27K ﹤0.01% 384
2025
Q3 		$390K Sell
14,852
-9,112
-38% -$272K ﹤0.01% 430
2025
Q2 		$635K Buy
+23,964
New +$631K ﹤0.01% 352

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Financial Engines Advisors's VKTX Position: Q2 2026 in Review

Financial Engines Advisors reduced its Viking Therapeutics (VKTX) stake by 0.49% in Q2 2026, selling an estimated $2.49K and leaving 15,584 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Financial Engines Advisors first reported a position in VKTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $635K in Q2 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Financial Engines Advisors held 15,584 shares of Viking Therapeutics worth $608K as of Q2 2026.
  • Financial Engines Advisors sold 77 Viking Therapeutics shares in Q2 2026, an estimated $2.49K.
  • Viking Therapeutics made up ﹤0.01% of Financial Engines Advisors's portfolio in Q2 2026, its #378 holding.
  • Financial Engines Advisors first reported a position in Viking Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Financial Engines Advisors's Viking Therapeutics position peaked at $635K in Q2 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Financial Engines Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.